Valuation : Integra LifeSciences Holdings Corporation

Market Cap 1.21B 1.04B 984M 892M 1.67B 115B 1.68B 11.65B 4.49B 58.54B 4.53B 4.43B 185B P/E 2026 *
24.2x
P/E 2027 * 12.4x
Enterprise Value 2.69B 2.32B 2.2B 1.99B 3.74B 257B 3.76B 26.04B 10.04B 131B 10.12B 9.9B 413B EV / Sales 2026 *
1.61x
EV / Sales 2027 * 1.44x
Free-Float
72.35%
Yield 2026 *
-
Yield 2027 * -
1 day-0.26%
1 week-7.30%
Current month-8.39%
1 month-10.82%
3 months-12.77%
6 months+69.03%
Current year+24.80%
1 week 15.33
Extreme 15.33
16.55
1 month 15.33
Extreme 15.33
18.45
Current year 8.7
Extreme 8.7
20.49
1 year 8.7
Extreme 8.7
20.49
3 years 8.7
Extreme 8.7
45.42
5 years 8.7
Extreme 8.7
74.98
10 years 8.7
Extreme 8.7
77.4
Manager TitleAgeSince
Chief Executive Officer 64 2026-04-30
Director of Finance/CFO 54 2023-06-27
Chief Tech/Sci/R&D Officer - 2026-02-16
Director TitleAgeSince
Chairman 64 2012-01-02
Director/Board Member 81 1991-12-31
Director/Board Member 65 2005-12-31
Date Insider Type Main position Quantity % Market Cap. Importance
9/1/26 Tax

Head of Human Resources

-1,455 0.0019%
7/3/26 Tax

Chief Financial Officer

-5,226 0.0067%
7/1/26 Free

Executive/Senior Manager

5,590 0.0072%
Change 5-day change 1-year change 3-year change Capi.($)
-0.26%-7.30%+2.92%-60.38% 1.21B
-1.36%-5.89%-23.76%-0.44% 176B
-0.72%-3.41%-3.26%+12.32% 116B
+0.19%-2.83%+6.30%+80.17% 61.36B
-1.92%-6.01%+7.05%+38.44% 49.42B
+0.81%-3.73%-4.81%-32.56% 48.44B
-1.75%-5.54%+8.93%-20.82% 31.33B
+0.43%-11.10% - - 28.54B
+0.58%+1.84%+36.58%-12.08% 24.37B
+0.49%-7.65%-13.30%+3.79% 21.57B
Average -0.35%-5.30%+1.85%+0.94% 55.9B
Weighted average by Cap. -0.69%-4.90%-6.00%+10.67%

Financials

2026 *2027 *
Net sales 1.67B 1.44B 1.37B 1.24B 2.32B 160B 2.34B 16.18B 6.24B 81.32B 6.29B 6.15B 257B 1.73B 1.49B 1.41B 1.28B 2.4B 165B 2.41B 16.69B 6.44B 83.9B 6.49B 6.34B 265B
Net income 42.03M 36.25M 34.31M 31.09M 58.29M 4.02B 58.68M 406M 157M 2.04B 158M 154M 6.45B 78.69M 67.87M 64.24M 58.2M 109M 7.52B 110M 760M 293M 3.82B 295M 289M 12.07B
Net Debt 1.49B 1.28B 1.22B 1.1B 2.07B 142B 2.08B 14.39B 5.55B 72.33B 5.59B 5.47B 228B 1.28B 1.11B 1.05B 950M 1.78B 123B 1.79B 12.42B 4.79B 62.4B 4.82B 4.72B 197B
Logo Integra LifeSciences Holdings Corporation
Integra LifeSciences Holdings Corporation is a global medical technology company. It manufactures and sells medical technologies and products in two segments: Codman Specialty Surgical (CSS) and Tissue Technologies (TT). CSS consists of technologies and instrumentations used for specialties, such as neurosurgery, neurocritical care, and otolaryngology. CSS neurosurgical business includes a portfolio of brands, which are used for the management of multiple disease states, including brain tumors, traumatic brain injury, hydrocephalus and other neurological conditions. It provides instruments that are used in precision, specialty and general surgical procedures. TT includes Wound Reconstruction and Care business, which sells offerings, such as skin and wound repair, plastics and surgical reconstruction products and nerve and tendon repair products. Its products include CUSA Platform, Codman Neurosurgical Accessories, DuraGen Dural Graft Matrix, DuraSeal Dural Sealant System and others.
Employees
4,427
Date Price Change Volume
26-09-11 US$15.50 -0.26% 792,028
26-09-10 US$15.54 -4.37% 1,361,972
26-09-09 US$16.25 -0.06% 578,400
26-09-08 US$16.26 -2.75% 621,796
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
12
Last Close Price
15.50USD
Average target price
19.56USD
Spread / Average Target
+26.16%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IART Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!